Baseline characteristics of the ECLAP population
| . | Data . |
|---|---|
| Women, no. (%) | 696 (42.5) |
| Mean age at diagnosis ± SD, y | 60.4 ± 13.2 |
| Age at recruitment | |
| Mean ± SD, y | 65.4 ± 12.7 |
| Less than 55 y, no. (%) | 316 (19.3) |
| 55-64 y, no. (%) | 387 (23.6) |
| 65-74 y, no. (%) | 561 (34.3) |
| 75 y or more, no. (%) | 374 (22.8) |
| Time from diagnosis of PV to enrollment | |
| Mean ± SD, y | 5.0 ± 5.0 |
| 0-2 y, no. (%) | 581 (35.5) |
| 3-4 y, no. (%) | 306 (18.7) |
| 5-6 y, no. (%) | 233 (14.2) |
| 7-10 y, no. (%) | 282 (17.2) |
| More than 10 y, no. (%) | 236 (14.4) |
| Prior bleeding, no. (%) | 133 (8.1) |
| Prior thrombosis, no. (%) | 587 (35.8) |
| Erythromelalgia, no. (%) | 86 (5.3) |
| Intermittent claudication, no. (%) | 77 (4.7) |
| Smoking, no. (%) | 209 (12.8) |
| Hypertension, no. (%) | 647 (39.5) |
| Diabetes mellitus, no. (%) | 117 (7.1) |
| . | Data . |
|---|---|
| Women, no. (%) | 696 (42.5) |
| Mean age at diagnosis ± SD, y | 60.4 ± 13.2 |
| Age at recruitment | |
| Mean ± SD, y | 65.4 ± 12.7 |
| Less than 55 y, no. (%) | 316 (19.3) |
| 55-64 y, no. (%) | 387 (23.6) |
| 65-74 y, no. (%) | 561 (34.3) |
| 75 y or more, no. (%) | 374 (22.8) |
| Time from diagnosis of PV to enrollment | |
| Mean ± SD, y | 5.0 ± 5.0 |
| 0-2 y, no. (%) | 581 (35.5) |
| 3-4 y, no. (%) | 306 (18.7) |
| 5-6 y, no. (%) | 233 (14.2) |
| 7-10 y, no. (%) | 282 (17.2) |
| More than 10 y, no. (%) | 236 (14.4) |
| Prior bleeding, no. (%) | 133 (8.1) |
| Prior thrombosis, no. (%) | 587 (35.8) |
| Erythromelalgia, no. (%) | 86 (5.3) |
| Intermittent claudication, no. (%) | 77 (4.7) |
| Smoking, no. (%) | 209 (12.8) |
| Hypertension, no. (%) | 647 (39.5) |
| Diabetes mellitus, no. (%) | 117 (7.1) |